Irene Pulido

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The objective of this clinical open-label trial was to test the safety, tolerability and efficacy of IGF-1 therapy for autosomal dominant cerebellar ataxia (ADCA) patients. A total of 19 molecularly confirmed patients with SCA3, 1 patient with SCA6 and 6 patients with SCA7 completed our study. They were 8 females and 18 males, 28 to 74 years of age (average(More)
This book is supported by the Global Health Education Consortium, a non-profit organization of allied health professionals and educators dedicated to global health education in health professions schools and graduate medical education residency programs. Electronic versions of this textbook are available on the Global Health Education Consortium website at(More)
  • 1